Loading...

AB Science S.A.

ABSCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.37
$0.00(0.00%)
U.S. Market opens in 14h 21m

AB Science S.A. (ABSCF) Stock Overview

Explore AB Science S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap90.7M
P/E Ratio-7.82
EPS (TTM)$-0.17
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$1.62
3 Months$1.79
1 Year Target$0.49

ABSCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AB Science S.A. (ABSCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.82 and a market capitalization of 90.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-5.52%
3-Month Change
-5.52%
6-Month Change
8.73%
Year-to-Date (YTD) Change
-5.52%
1-Year Change
-12.74%
3-Year Change
-84.78%
5-Year Change
-93.12%
All-Time (Max) Change
-84.78%

Contact Information

33 1 47 20 00 14
3, Avenue George V, Paris, NaN, 75008

Company Facts

40 Employees
IPO DateSep 9, 2011
CountryFR
Actively Trading

Frequently Asked Questions